Works matching IS 02698811 AND DT 2011 AND VI 25 AND IP 9
Results: 18
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Special issue on CNS experimental medicine.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Sleep and its disorders in translational medicine.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Sleep and its disorders in translational medicine.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1226, doi. 10.1177/0269881111400643
- By:
- Publication type:
- Article
Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1235, doi. 10.1177/0269881110388324
- By:
- Publication type:
- Article
The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1175, doi. 10.1177/0269881110388323
- By:
- Publication type:
- Article
Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1256, doi. 10.1177/0269881110379285
- By:
- Publication type:
- Article
The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1199, doi. 10.1177/0269881111400650
- By:
- Publication type:
- Article
Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Special issue on CNS experimental medicine.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1145, doi. 10.1177/0269881111415342
- By:
- Publication type:
- Article
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1207, doi. 10.1177/0269881111414450
- By:
- Publication type:
- Article
Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD).
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1192, doi. 10.1177/0269881111408455
- By:
- Publication type:
- Article
Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1159, doi. 10.1177/0269881110376689
- By:
- Publication type:
- Article
Using MRI to measure drug action: caveats and new directions.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1168, doi. 10.1177/0269881110372547
- By:
- Publication type:
- Article
Efficacy markers in depression.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 9, p. 1148, doi. 10.1177/0269881110367722
- By:
- Publication type:
- Article